slides · global inventory
Sequoia Pitch
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 43,093
Current window 25,411-25,440
Pages 1,437
Rows per page 30
Arc
25,411-25,440 of 43,093
10
The slide uses a combination of logo-based segmentation and a grouped bar chart to illustrate portfolio composition and financial scale.Kering | Fixed Income Presentation Deck | 35 slides · Kering
Deck Investor relations Beat · Solution1 hit
11
The slide uses a pie-chart-like visual to represent strategic pillars. The revenue chart shows growth from 2012 to 2022.Kering | Fixed Income Presentation Deck | 35 slides · Kering
Deck Investor relations Beat · Solution1 hit
12
The slide uses a combination of a bar chart for Eyewear revenue growth and a timeline for Beauté development.Kering | Fixed Income Presentation Deck | 35 slides · Kering
Deck Investor relations Beat · Solution1 hit
13
Kering | Fixed Income Presentation Deck | 35 slidesKering | Fixed Income Presentation Deck | 35 slides · Kering
Deck Investor relations Beat · Solution1 hit
14
Kering | Fixed Income Presentation Deck | 35 slidesKering | Fixed Income Presentation Deck | 35 slides · Kering
Deck Investor relations Beat · Financials1 hit
15
Kering | Fixed Income Presentation Deck | 35 slidesKering | Fixed Income Presentation Deck | 35 slides · Kering
Deck Investor relations Beat · FinancialsLoop · Zoom In1 hit
16
The chart is a waterfall bridge showing the transition from Q3 22 to Q3 23 revenue.Kering | Fixed Income Presentation Deck | 35 slides · Kering
Deck Investor relations Beat · FinancialsLoop · Zoom In1 hit
17
The slide uses a table for segment performance and a donut chart with a map overlay for regional performance.Kering | Fixed Income Presentation Deck | 35 slides · Kering
Deck Investor relations Beat · FinancialsLoop · Zoom In1 hit
18
The slide uses a donut chart to show the split between Retail (78%) and Wholesale (22%) channels, with YoY growth percentages for each segment.Kering | Fixed Income Presentation Deck | 35 slides · Kering
Deck Investor relations Beat · FinancialsLoop · Zoom In1 hit
19
Kering | Fixed Income Presentation Deck | 35 slidesKering | Fixed Income Presentation Deck | 35 slides · Kering
Deck Investor relations Beat · Financials1 hit
03
The slide uses a split-layout with a branding/mission sidebar and a bulleted list of key achievements.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
04
Kymera | Investor Presentation Deck | 41 slidesKymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
TPD = Targeted Protein Degradation. UD = Undrugged, ID = Inadequately drugged.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · Solution1 hit
06
The slide uses a standard pharmaceutical pipeline table format.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · Solution1 hit
10
Kymera | Investor Presentation Deck | 41 slidesKymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
11
Includes both a longitudinal line chart of IRAK4 reduction and a grouped bar chart with a summary table for cytokine inhibition.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
12
Includes PK/PD correlation, IRAK4 levels in PBMC, and skin lesion reduction data.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
13
The slide displays 12 bar charts representing log2(fold change) for specific genes across individual patients.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
14
Includes error bars representing standard error of the mean; data points are plotted over 42 days.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
15
The slide includes a disclaimer regarding the non-head-to-head nature of the comparison.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
16
Data includes error bars representing standard error of the mean (S.E. of Mean) or 80% confidence intervals.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
17
The slide includes a disclaimer regarding the non-head-to-head nature of the comparison.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
18
The slide highlights a favorable safety profile with no serious adverse events (SAEs) or drug-related infections.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
19
Focuses on partnership dynamics and clinical progress.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
40
Kymera | Investor Presentation Deck | 41 slidesKymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · Roadmap1 hit
41
Kymera | Investor Presentation Deck | 41 slidesKymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · Roadmap1 hit
03
The slide uses a list-based layout to present key company milestones and financial health.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Executive Summary1 hit
04
The slide uses a two-column layout to contrast the current Phase 2 trial status with the upcoming OLE trial status.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
05
The slide uses a timeline framework to demonstrate long-term IP protection.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
07
The slide uses clinical data to establish the biological rationale for the therapeutic approach.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit